Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case–Control Study, Europe 2014/15
Marta Valenciano(World Health Organization), Lisa Domegan(Health Service Executive), Esther Kissling, Caterina Rizzo(University of Pisa), Daniela Pițigoi(Carol Davila University of Medicine and Pharmacy), Iwona Paradowska‐Stankiewicz(Narodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy), Annamária Ferenczi(Semmelweis University), Antonino Bella(Istituto Superiore di Sanità), Amparo Larrauri(Instituto de Salud Carlos III), Alin Gherasim(Instituto de Salud Carlos III), J Horváth(Semmelweis University), Annicka Reuß(Robert Koch Institute), Ausenda Machado(National Institute of Health Dr. Ricardo Jorge)
Cited by 81
Related Papers
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
|Eurosurveillance|2020|715
ChatGPT and the rise of large language models: the new AI-driven infodemic threat in public health
|Frontiers in Public Health|2023|640
Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study
|PLoS Medicine|2011|303